Back to Vanguard Personalized Indexing Management, LLC Vanguard Personalized Indexing Management, LLC

STLNSTLN

Showing 1 of 5 quarters

Position history for Vanguard Personalized Indexing Management, LLCVanguard Personalized Indexing Management, LLC's holdings in Starling Oncology, Inc.

No. Vanguard Personalized Indexing Management exited its STLN (Starling Oncology) position in Q3 2024. Its Q2 2024 13F listed 17,984 shares worth $8,273. Vanguard Personalized Indexing Management first reported STLN in Q3 2023 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$0.33
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used